All Articles

With the appointment of Roku and Viant veteran Tom Wolfe, Locality signals a major play to solve local TV's biggest challenges: fragmentation and opacity.

Co-Diagnostics is developing a point-of-care Ebola test promising 30-minute results. But can it navigate regulatory hurdles and reach the front lines in time?

With real estate worth more than its stock and ambitious R&D plans, Cosmos Health claims it's undervalued. But is an unusual crypto strategy clouding the picture?

JFrog's inclusion in the Russell 3000 isn't just a corporate win; it's a signal of the market's new respect for the software supply chain's vital role.

While others chase fleeting trends, one Colorado agency built a decade of success on a radical idea: sustainability over scale. Here's the analysis.

With an $18M Series A, Novellia is flipping the script on real-world data, empowering patients to solve a decades-old, multi-billion-dollar R&D bottleneck.

With a $1.25 billion investment from Apollo Funds, McKesson is spinning off its medical supply unit. Is this a cure for corporate bloat or a new symptom of financialization in healthcare?

As AI-powered cyberattacks escalate, one company is fighting fire with fire. Skyhawk Security's award-winning AI Red Team is a game-changer.

TELUS's #StandWithOwners returns, but its new focus on a year-round community reveals a deeper strategy: building an ecosystem, not just running a contest.

AI is moving from the cloud to the world around us. New, powerful hardware is making our cities and industries smarter, but it demands a new level of trust.

Frazier Healthcare Partners adds Milton Boyer as an EIR, signaling a strategic push into the complex pharmaceutical manufacturing sector with a proven operator.

The Dallas Cowboys are using a new device to build muscle. It’s part of a high-stakes trend where technology is redefining athlete recovery and longevity.

An analysis of 89 school districts reveals a new data-driven playbook for reducing chronic absenteeism, with major implications for EdTech and human capital.

A new study on couples' supplements shows impressive well-being gains, but a closer look at the methodology reveals a gap between marketing and hard science.

At InfoComm 2026, Taiwan isn't just selling hardware. It's unveiling a national strategy to dominate the future of AI-driven enterprise technology.

Shift Browser's Impact Grant isn't just about money; it's a new blueprint for how the tech industry can fund the very solutions needed to fix its own mess.

A new partnership between SoundExchange and IFPI automates a critical piece of music's data puzzle, promising fairer pay and less bureaucracy for indie artists.

Neil Jesani Advisors' high-profile board appointments reveal a new playbook for growth, where political savvy and tech innovation are the ultimate currency.

As Recursion heads to a key investor conference, it must prove its AI-powered drug discovery platform can deliver financial results, not just scientific promise.

A new partnership is democratizing science for wellness brands, making it faster and cheaper to prove their final products work and earn customer trust.